Autologous CAR T-Cells RD14-01
autologous car t-cells rd14-01
"A preparation of autologous T-lymphocytes that are genetically engineered to express a chimeric antigen receptor (CAR) that targets an as of yet unidentified tumor-associated antigen (TAA), with potential immunomodulatory and antineoplastic activities. Upon administration of autologous CAR T-cells RD14-01, the T-cells target, bind to and induce selective cytotoxicity in tumor cells expressing the TAA."